共 50 条
- [21] Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 937 - 938
- [23] Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
- [24] Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications Diabetology & Metabolic Syndrome, 13
- [25] Microvascular disease in diabetes and severe COVID-19 outcomes LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (04): : 200 - 201
- [26] Diabetes, Obesity, and Risk Prediction of Severe COVID-19 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10):
- [29] Pulmonary Complications are common after a severe Course of COVID-19 PNEUMOLOGIE, 2021, 75 (04): : 256 - 256